25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

LifeMD Inc
Buy, Hold or Sell?

Let's analyze Lifemd together

I guess you are interested in LifeMD Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of LifeMD Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about LifeMD Inc

I send you an email if I find something interesting about LifeMD Inc.

1. Quick Overview

1.1. Quick analysis of Lifemd (30 sec.)










1.2. What can you expect buying and holding a share of Lifemd? (30 sec.)

How much money do you get?

How much money do you get?
$0.07
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
$-0.14
Expected worth in 1 year
$-0.02
How sure are you?
42.5%

+ What do you gain per year?

Total Gains per Share
$0.20
Return On Investment
4.0%

For what price can you sell your share?

Current Price per Share
$4.82
Expected price per share
$3.99 - $7.09
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Lifemd (5 min.)




Live pricePrice per Share (EOD)
$4.82
Intrinsic Value Per Share
$-1.24 - $12.94
Total Value Per Share
$-1.38 - $12.80

2.2. Growth of Lifemd (5 min.)




Is Lifemd growing?

Current yearPrevious yearGrowGrow %
How rich?-$5.9m-$8.9m$8.7m3,028.0%

How much money is Lifemd making?

Current yearPrevious yearGrowGrow %
Making money-$5.8m-$8.6m$2.8m48.2%
Net Profit Margin-13.0%-26.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Lifemd (5 min.)




2.4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Lifemd?

Welcome investor! Lifemd's management wants to use your money to grow the business. In return you get a share of Lifemd.

First you should know what it really means to hold a share of Lifemd. And how you can make/lose money.

Speculation

The Price per Share of Lifemd is $4.82. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lifemd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lifemd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.14. Based on the TTM, the Book Value Change Per Share is $0.03 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lifemd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.14-2.9%-0.14-2.9%-0.18-3.8%-0.26-5.3%-0.13-2.8%
Usd Book Value Change Per Share-0.09-1.9%0.030.6%-0.08-1.7%-0.01-0.1%0.00-0.1%
Usd Dividend Per Share0.020.4%0.020.4%0.020.4%0.020.3%0.010.2%
Usd Total Gains Per Share-0.07-1.5%0.051.0%-0.07-1.4%0.010.2%0.000.1%
Usd Price Per Share5.24-7.67-3.56-4.95-2.59-
Price to Earnings Ratio-9.36--14.83--5.56--6.15-21.49-
Price-to-Total Gains Ratio-70.88--71.79--641.45--144.01-3.56-
Price to Book Ratio-37.12-54.77--15.68--2.62--1.05-
Price-to-Total Gains Ratio-70.88--71.79--641.45--144.01-3.56-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.82
Number of shares207
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.03-0.01
Usd Total Gains Per Share0.050.01
Gains per Quarter (207 shares)10.101.95
Gains per Year (207 shares)40.417.78
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
115253013-5-2
230507026-116
3467511039-1614
46110115052-2122
57612619065-2630
69115123078-3238
710717627091-3746
8122201310105-4254
9137226350118-4862
10152252390131-5370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%2.038.00.05.0%2.049.00.03.9%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%4.016.00.020.0%14.023.03.035.0%17.029.05.033.3%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%16.00.04.080.0%20.00.020.050.0%20.00.031.039.2%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%17.022.01.042.5%20.028.03.039.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of LifeMD Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0920.030-404%-0.084-9%-0.006-93%-0.004-96%
Book Value Per Share---0.141-0.007-95%-0.213+51%-0.023-84%-0.010-93%
Current Ratio--0.8250.979-16%0.619+33%0.8280%1.043-21%
Debt To Asset Ratio--1.0821.000+8%1.266-14%1.297-17%1.167-7%
Debt To Equity Ratio---3.774-100%-0%2.211-100%1.680-100%
Dividend Per Share--0.0180.018+0%0.018+0%0.016+17%0.008+122%
Enterprise Value--180152583.000294519284.500-39%117962105.250+53%191272391.200-6%99925912.225+80%
Eps---0.140-0.138-1%-0.184+32%-0.256+83%-0.133-5%
Ev To Ebitda Ratio---21.153-104.952+396%-11.303-47%-25.379+20%-21.032-1%
Ev To Sales Ratio--1.1181.638-32%0.825+36%1.884-41%2.204-49%
Free Cash Flow Per Share--0.0640.063+2%-0.042+166%-0.091+242%-0.048+175%
Free Cash Flow To Equity Per Share--0.0450.132-66%0.056-20%0.045-1%0.022+101%
Gross Profit Margin--5.5045.344+3%3.325+66%3.294+67%2.874+92%
Intrinsic Value_10Y_max--12.942--------
Intrinsic Value_10Y_min---1.239--------
Intrinsic Value_1Y_max--0.023--------
Intrinsic Value_1Y_min---0.259--------
Intrinsic Value_3Y_max--1.039--------
Intrinsic Value_3Y_min---0.666--------
Intrinsic Value_5Y_max--3.227--------
Intrinsic Value_5Y_min---0.947--------
Market Cap203360138.000-9%221080316.000323498725.750-32%150199604.000+47%208718382.300+6%109063476.500+103%
Net Profit Margin---0.147-0.130-12%-0.265+81%-0.543+270%-0.460+214%
Operating Margin---0.116-0.107-8%-0.136+17%-0.479+312%-0.416+258%
Operating Ratio--0.9291.061-12%1.146-19%1.478-37%1.449-36%
Pb Ratio-34.149+8%-37.12554.773-168%-15.681-58%-2.618-93%-1.047-97%
Pe Ratio-8.605+8%-9.355-14.832+59%-5.559-41%-6.154-34%21.489-144%
Price Per Share4.820-9%5.2407.668-32%3.560+47%4.947+6%2.585+103%
Price To Free Cash Flow Ratio18.763-9%20.39833.201-39%-9.900+149%1.903+972%0.307+6555%
Price To Total Gains Ratio-65.200+8%-70.882-71.791+1%-641.449+805%-144.011+103%3.563-2089%
Quick Ratio--0.7400.888-17%0.463+60%0.657+13%0.682+8%
Return On Assets---0.081-0.091+11%-0.272+234%-0.676+730%-0.508+524%
Return On Equity----0.2660%-0%-1.6650%-1.0440%
Total Gains Per Share---0.0740.049-251%-0.066-11%0.009-887%0.005-1641%
Usd Book Value---5955064.000-287373.250-95%-8988943.250+51%-970804.350-84%-421988.625-93%
Usd Book Value Change Per Share---0.0920.030-404%-0.084-9%-0.006-93%-0.004-96%
Usd Book Value Per Share---0.141-0.007-95%-0.213+51%-0.023-84%-0.010-93%
Usd Dividend Per Share--0.0180.018+0%0.018+0%0.016+17%0.008+122%
Usd Enterprise Value--180152583.000294519284.500-39%117962105.250+53%191272391.200-6%99925912.225+80%
Usd Eps---0.140-0.138-1%-0.184+32%-0.256+83%-0.133-5%
Usd Free Cash Flow--2709621.0002656560.250+2%-1787524.250+166%-3860435.950+242%-2035091.075+175%
Usd Free Cash Flow Per Share--0.0640.063+2%-0.042+166%-0.091+242%-0.048+175%
Usd Free Cash Flow To Equity Per Share--0.0450.132-66%0.056-20%0.045-1%0.022+101%
Usd Market Cap203360138.000-9%221080316.000323498725.750-32%150199604.000+47%208718382.300+6%109063476.500+103%
Usd Price Per Share4.820-9%5.2407.668-32%3.560+47%4.947+6%2.585+103%
Usd Profit---5908028.000-5821031.250-1%-8628383.000+46%-10652386.450+80%-5537135.225-6%
Usd Revenue--40275546.00044985375.500-10%33951718.750+19%27038817.550+49%14213127.425+183%
Usd Total Gains Per Share---0.0740.049-251%-0.066-11%0.009-887%0.005-1641%
 EOD+3 -5MRQTTM+14 -25YOY+29 -95Y+24 -1510Y+23 -16

3.3 Fundamental Score

Let's check the fundamental score of LifeMD Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.605
Price to Book Ratio (EOD)Between0-1-34.149
Net Profit Margin (MRQ)Greater than0-0.147
Operating Margin (MRQ)Greater than0-0.116
Quick Ratio (MRQ)Greater than10.740
Current Ratio (MRQ)Greater than10.825
Debt to Asset Ratio (MRQ)Less than11.082
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.081
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of LifeMD Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.180
Ma 20Greater thanMa 505.129
Ma 50Greater thanMa 1005.560
Ma 100Greater thanMa 2005.207
OpenGreater thanClose4.980
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About LifeMD Inc

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Fundamental data was last updated by Penke on 2025-01-17 00:51:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Lifemd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Lifemd to the Health Information Services industry mean.
  • A Net Profit Margin of -14.7% means that $-0.15 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of LifeMD Inc:

  • The MRQ is -14.7%. The company is making a huge loss. -2
  • The TTM is -13.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-14.7%TTM-13.0%-1.7%
TTM-13.0%YOY-26.5%+13.6%
TTM-13.0%5Y-54.3%+41.3%
5Y-54.3%10Y-46.0%-8.2%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.7%-13.5%-1.2%
TTM-13.0%-19.9%+6.9%
YOY-26.5%-15.0%-11.5%
5Y-54.3%-22.7%-31.6%
10Y-46.0%-33.6%-12.4%
4.3.1.2. Return on Assets

Shows how efficient Lifemd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lifemd to the Health Information Services industry mean.
  • -8.1% Return on Assets means that Lifemd generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of LifeMD Inc:

  • The MRQ is -8.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.1%TTM-9.1%+0.9%
TTM-9.1%YOY-27.2%+18.1%
TTM-9.1%5Y-67.6%+58.5%
5Y-67.6%10Y-50.8%-16.7%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.1%-4.6%-3.5%
TTM-9.1%-5.3%-3.8%
YOY-27.2%-5.5%-21.7%
5Y-67.6%-5.2%-62.4%
10Y-50.8%-7.1%-43.7%
4.3.1.3. Return on Equity

Shows how efficient Lifemd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lifemd to the Health Information Services industry mean.
  • 0.0% Return on Equity means Lifemd generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of LifeMD Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-26.6%+26.6%
TTM-26.6%YOY--26.6%
TTM-26.6%5Y-166.5%+139.9%
5Y-166.5%10Y-104.4%-62.1%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ--2.4%+2.4%
TTM-26.6%-4.8%-21.8%
YOY--5.4%+5.4%
5Y-166.5%-8.0%-158.5%
10Y-104.4%-9.0%-95.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of LifeMD Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Lifemd is operating .

  • Measures how much profit Lifemd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lifemd to the Health Information Services industry mean.
  • An Operating Margin of -11.6% means the company generated $-0.12  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of LifeMD Inc:

  • The MRQ is -11.6%. The company is operating very inefficient. -2
  • The TTM is -10.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-11.6%TTM-10.7%-0.9%
TTM-10.7%YOY-13.6%+2.9%
TTM-10.7%5Y-47.9%+37.2%
5Y-47.9%10Y-41.6%-6.3%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.6%-15.6%+4.0%
TTM-10.7%-20.3%+9.6%
YOY-13.6%-9.4%-4.2%
5Y-47.9%-16.0%-31.9%
10Y-41.6%-24.9%-16.7%
4.3.2.2. Operating Ratio

Measures how efficient Lifemd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 0.93 means that the operating costs are $0.93 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of LifeMD Inc:

  • The MRQ is 0.929. The company is less efficient in keeping operating costs low.
  • The TTM is 1.061. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.929TTM1.061-0.131
TTM1.061YOY1.146-0.086
TTM1.0615Y1.478-0.418
5Y1.47810Y1.449+0.030
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9291.289-0.360
TTM1.0611.343-0.282
YOY1.1461.329-0.183
5Y1.4781.302+0.176
10Y1.4491.306+0.143
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of LifeMD Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Lifemd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 0.83 means the company has $0.83 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of LifeMD Inc:

  • The MRQ is 0.825. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.979. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.825TTM0.979-0.154
TTM0.979YOY0.619+0.360
TTM0.9795Y0.828+0.152
5Y0.82810Y1.043-0.216
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8251.660-0.835
TTM0.9791.660-0.681
YOY0.6191.845-1.226
5Y0.8282.586-1.758
10Y1.0432.576-1.533
4.4.3.2. Quick Ratio

Measures if Lifemd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lifemd to the Health Information Services industry mean.
  • A Quick Ratio of 0.74 means the company can pay off $0.74 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of LifeMD Inc:

  • The MRQ is 0.740. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.888. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.740TTM0.888-0.148
TTM0.888YOY0.463+0.425
TTM0.8885Y0.657+0.231
5Y0.65710Y0.682-0.025
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7401.217-0.477
TTM0.8881.224-0.336
YOY0.4631.350-0.887
5Y0.6572.067-1.410
10Y0.6822.266-1.584
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of LifeMD Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Lifemd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lifemd to Health Information Services industry mean.
  • A Debt to Asset Ratio of 1.08 means that Lifemd assets are financed with 108.2% credit (debt) and the remaining percentage (100% - 108.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of LifeMD Inc:

  • The MRQ is 1.082. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.000. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ1.082TTM1.000+0.083
TTM1.000YOY1.266-0.266
TTM1.0005Y1.297-0.298
5Y1.29710Y1.167+0.130
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0820.411+0.671
TTM1.0000.407+0.593
YOY1.2660.429+0.837
5Y1.2970.422+0.875
10Y1.1670.434+0.733
4.5.4.2. Debt to Equity Ratio

Measures if Lifemd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lifemd to the Health Information Services industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of LifeMD Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.774-3.774
TTM3.774YOY-+3.774
TTM3.7745Y2.211+1.562
5Y2.21110Y1.680+0.531
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.550-0.550
TTM3.7740.561+3.213
YOY-0.630-0.630
5Y2.2110.602+1.609
10Y1.6800.612+1.068
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Lifemd generates.

  • Above 15 is considered overpriced but always compare Lifemd to the Health Information Services industry mean.
  • A PE ratio of -9.36 means the investor is paying $-9.36 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of LifeMD Inc:

  • The EOD is -8.605. Based on the earnings, the company is expensive. -2
  • The MRQ is -9.355. Based on the earnings, the company is expensive. -2
  • The TTM is -14.832. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.605MRQ-9.355+0.750
MRQ-9.355TTM-14.832+5.477
TTM-14.832YOY-5.559-9.273
TTM-14.8325Y-6.154-8.678
5Y-6.15410Y21.489-27.643
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-8.605-0.990-7.615
MRQ-9.355-0.986-8.369
TTM-14.832-1.303-13.529
YOY-5.559-2.370-3.189
5Y-6.154-3.147-3.007
10Y21.489-3.928+25.417
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of LifeMD Inc:

  • The EOD is 18.763. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 20.398. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 33.201. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD18.763MRQ20.398-1.635
MRQ20.398TTM33.201-12.803
TTM33.201YOY-9.900+43.101
TTM33.2015Y1.903+31.297
5Y1.90310Y0.307+1.597
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD18.763-0.228+18.991
MRQ20.398-0.820+21.218
TTM33.201-1.258+34.459
YOY-9.900-4.429-5.471
5Y1.903-6.724+8.627
10Y0.307-3.992+4.299
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Lifemd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of -37.12 means the investor is paying $-37.12 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of LifeMD Inc:

  • The EOD is -34.149. Based on the equity, the company is expensive. -2
  • The MRQ is -37.125. Based on the equity, the company is expensive. -2
  • The TTM is 54.773. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-34.149MRQ-37.125+2.976
MRQ-37.125TTM54.773-91.897
TTM54.773YOY-15.681+70.453
TTM54.7735Y-2.618+57.391
5Y-2.61810Y-1.047-1.571
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-34.1491.786-35.935
MRQ-37.1251.857-38.982
TTM54.7731.845+52.928
YOY-15.6812.088-17.769
5Y-2.6183.902-6.520
10Y-1.0474.148-5.195
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of LifeMD Inc.

4.8.1. Institutions holding LifeMD Inc

Institutions are holding 40.414% of the shares of LifeMD Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30BlackRock Inc5.72990.000324817611450356.2068
2024-09-30Vanguard Group Inc3.93090.0002170256618402212.1183
2024-09-30Divisadero Street Capital Management, LP3.48260.95891508403100210.6688
2024-09-30State Street Corp2.66780.0003115549519286120.0347
2024-09-30Royce & Associates, LP2.08030.042990104111471014.588
2024-09-30Geode Capital Management, LLC1.89150.00048192338359811.3641
2024-09-30Connor Clark & Lunn Inv Mgmt Ltd1.76840.0195765916482016.7159
2024-09-30Millennium Management LLC1.7470.0019756660664329719.5081
2024-09-30AQR Capital Management LLC1.58680.0056872806872800
2024-09-30Qube Research & Technologies0.93440.0031404729-48411-10.6835
2024-09-30Uniplan Investment Counsel, Inc.0.90130.1785390352-6849-1.7243
2024-09-30Goldman Sachs Group Inc0.88750.0003384410267966230.1244
2024-09-30Renaissance Technologies Corp0.81090.002835120416801191.7126
2024-09-30Morgan Stanley - Brokerage Accounts0.78190.0001338651-914337-72.9725
2024-09-30Northern Trust Corp0.73270.0003317340240450312.7195
2024-09-30Nuveen Asset Management, LLC0.65580.000428403100
2024-09-30Quinn Opportunity Partners LLC0.6210.13632689662689660
2024-09-30Bridgeway Capital Management, LLC0.57990.02852511575940030.9767
2024-09-30Deerfield Management Co0.55720.0189241329201040498.9948
2024-09-30Bank of New York Mellon Corp0.48190.0002208741-25842-11.0161
Total 32.82971.398814219265+2340451+16.5%

4.9.2. Funds holding LifeMD Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-11-30Vanguard Total Stock Mkt Idx Inv2.1530.000393252800
2024-12-31iShares Russell 2000 ETF2.1310.0064922992-3550-0.3831
2024-11-30Vanguard Institutional Extnd Mkt Idx Tr1.21470.00295261257618016.931
2024-09-30Royce Small-Cap Opportunity Invmt1.20760.2224523026434009.0487
2024-11-30FTGF RY US SmCp Opp A USD Dis(A)1.03020.29414462155799114.9375
2024-10-31Fidelity Small Cap Index0.83030.0055359618-258-0.0717
2024-11-30Nuveen Equity Index R60.51010.002922091400
2024-09-30Bridgeway Ultra-Small Company0.50951.37082206578440061.9418
2024-12-31State St Russell Sm/Mid Cp® Indx NL Cl C0.49920.0024216209-3700-1.6825
2024-11-30Fidelity Extended Market Index0.48770.0031211249-1393-0.6551
2024-12-31iShares Russell 2000 Growth ETF0.46280.007920045700
2024-11-30Vanguard Russell 2000 ETF0.38780.00816798544402.7148
2024-12-31State St Russell Sm Cap® Indx SL Cl I0.34120.007714780000
2024-12-31iShares Russell 2000 Value ETF0.29060.0051125885-3528-2.7262
2024-11-30Schwab Small Cap Index0.20380.00828825760227.3229
2024-09-30NT R2000 Index Fund - NL0.20350.00788131881310
2024-12-31Extended Equity Market Fund K0.19960.0029864422780047.4063
2024-12-31iShares Micro-Cap ETF0.19360.04348386000
2024-10-31Goldman Sachs Small Cap Eq Insghts Instl0.18840.07698160400
2024-03-31Acuitas US Microcap Strategy0.16950.19137340000
Total 13.21412.26925723354+375935+6.6%

5.3. Insider Transactions

Insiders are holding 15.571% of the shares of LifeMD Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-01-02Justin SchreiberSELL250005.19
2024-12-02Justin SchreiberSELL250006.52
2024-09-11Stefan GalluppiBUY30004.93
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Operating Income  -4,5692,398-2,172-4,000-6,171-134-6,3069,1482,842
Cost of Revenue  4,7822,6337,414-9666,4481,3107,758-15,862-8,104



5.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets72,560
Total Liabilities78,515
Total Stockholder Equity-7,720
 As reported
Total Liabilities 78,515
Total Stockholder Equity+ -7,720
Total Assets = 72,560

Assets

Total Assets72,560
Total Current Assets48,657
Long-term Assets23,903
Total Current Assets
Cash And Cash Equivalents 37,587
Net Receivables 6,050
Inventory 2,645
Other Current Assets 2,375
Total Current Assets  (as reported)48,657
Total Current Assets  (calculated)48,657
+/-0
Long-term Assets
Property Plant Equipment 6,750
Intangible Assets 2,275
Long-term Assets Other 14,877
Long-term Assets  (as reported)23,903
Long-term Assets  (calculated)23,903
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities58,952
Long-term Liabilities19,563
Total Stockholder Equity-7,720
Total Current Liabilities
Short-term Debt 5,681
Accounts payable 15,867
Other Current Liabilities 18,746
Total Current Liabilities  (as reported)58,952
Total Current Liabilities  (calculated)40,294
+/- 18,658
Long-term Liabilities
Long-term Liabilities  (as reported)19,563
Long-term Liabilities  (calculated)0
+/- 19,563
Total Stockholder Equity
Common Stock419
Retained Earnings -235,370
Other Stockholders Equity 227,231
Total Stockholder Equity (as reported)-7,720
Total Stockholder Equity (calculated)-7,720
+/-0
Other
Cash and Short Term Investments 37,587
Common Stock Shares Outstanding 42,021
Current Deferred Revenue16,391
Liabilities and Stockholders Equity 72,560
Net Debt -12,443
Net Working Capital -10,295
Short Long Term Debt Total 25,144



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
> Total Assets 
0
0
452
370
365
462
293
551
328
302
313
175
216
252
245
448
641
866
1,079
790
790
1,074
1,337
1,264
1,264
1,838
1,899
2,616
2,616
2,199
2,546
3,446
2,291
3,024
5,429
13,054
18,744
23,988
16,352
49,923
50,290
37,969
33,362
25,666
33,870
35,446
40,691
58,481
61,455
63,820
72,560
72,56063,82061,45558,48140,69135,44633,87025,66633,36237,96950,29049,92316,35223,98818,74413,0545,4293,0242,2913,4462,5462,1992,6162,6161,8991,8381,2641,2641,3371,0747907901,07986664144824525221617531330232855129346236537045200
   > Total Current Assets 
0
0
279
212
222
333
178
451
241
230
255
131
187
236
245
448
641
866
1,079
790
790
1,074
1,337
1,264
1,264
1,471
1,564
1,605
1,605
1,329
1,761
2,747
1,572
2,191
4,653
12,063
17,838
22,480
14,133
44,921
29,579
18,510
12,974
11,311
19,165
20,181
24,886
42,604
44,409
45,069
48,657
48,65745,06944,40942,60424,88620,18119,16511,31112,97418,51029,57944,92114,13322,48017,83812,0634,6532,1911,5722,7471,7611,3291,6051,6051,5641,4711,2641,2641,3371,0747907901,07986664144824523618713125523024145117833322221227900
       Cash And Cash Equivalents 
0
0
163
99
39
111
47
155
36
61
90
75
70
80
74
233
204
235
474
183
183
381
563
141
141
691
407
180
180
265
781
1,107
358
336
917
9,179
13,407
17,414
9,447
41,328
25,085
11,717
5,837
3,959
11,525
11,907
15,288
33,147
35,111
35,703
37,587
37,58735,70335,11133,14715,28811,90711,5253,9595,83711,71725,08541,3289,44717,41413,4079,1799173363581,1077812651801804076911411415633811831834742352042337480707590613615547111399916300
       Net Receivables 
0
0
0
50
114
158
11
209
117
85
111
15
73
135
132
154
299
451
475
447
447
556
277
399
399
64
176
99
99
103
65
97
282
436
414
648
1,351
1,612
1,497
980
1,797
2,514
2,538
2,835
2,937
3,669
4,419
5,277
5,336
5,668
6,050
6,0505,6685,3365,2774,4193,6692,9372,8352,5382,5141,7979801,4971,6121,35164841443628297651039999176643993992775564474474754512991541321357315111851172091115811450000
       Other Current Assets 
0
0
0
0
0
0
0
132
0
0
0
0
0
0
0
0
0
0
0
0
2
0
120
0
17
125
251
0
270
126
116
443
316
329
370
155
105
447
689
793
843
873
815
687
1,074
672
1,304
1,906
1,877
1,754
2,375
2,3751,7541,8771,9061,3046721,0746878158738437936894471051553703293164431161262700251125170120020000000000001320000000
   > Long-term Assets 
0
0
172
158
143
129
115
101
86
72
58
44
30
15
0
0
0
0
0
0
0
0
0
0
0
367
335
0
1,011
870
785
699
719
833
777
990
906
1,508
2,219
5,002
20,711
19,459
20,388
14,354
14,705
15,265
15,805
15,876
17,047
18,751
23,903
23,90318,75117,04715,87615,80515,26514,70514,35420,38819,45920,7115,0022,2191,5089069907778337196997858701,01103353670000000000015304458728610111512914315817200
       Property Plant Equipment 
0
0
172
158
143
129
115
101
86
72
58
44
30
15
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28
27
25
24
22
20
18
274
250
243
268
1,986
2,140
2,018
1,823
1,682
1,577
1,373
1,224
1,071
2,260
3,658
6,750
6,7503,6582,2601,0711,2241,3731,5771,6821,8232,0182,1401,986268243250274182022242527280000000000000015304458728610111512914315817200
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,455
6,720
5,655
0
0
0
0
0
0
0
0
000000005,6556,7209,4550000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
367
335
1,011
1,011
843
759
675
697
813
758
716
656
1,264
1,951
3,016
9,116
10,722
12,910
12,672
13,128
13,893
14,581
14,805
14,787
15,093
2,275
2,27515,09314,78714,80514,58113,89313,12812,67212,91010,7229,1163,0161,9511,2646567167588136976757598431,0111,0113353670000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
209
235
244
282
252
356
245
288
344
315
352
417
382
267
437
522
622
1,152
1,152
2,397
777
641
641
511
700
1,796
1,796
3,628
3,114
4,575
6,000
7,904
13,394
13,875
15,807
28,139
31,014
24,104
33,935
31,155
30,279
32,971
41,231
45,651
51,775
52,915
60,156
65,880
78,515
78,51565,88060,15652,91551,77545,65141,23132,97130,27931,15533,93524,10431,01428,13915,80713,87513,3947,9046,0004,5753,1143,6281,7961,7967005116416417772,3971,1521,15262252243726738241735231534428824535625228224423520900
   > Total Current Liabilities 
0
0
209
187
201
243
217
326
219
266
326
302
343
413
382
267
437
522
622
1,152
1,152
2,397
777
641
641
511
700
1,192
1,192
2,348
2,984
3,975
4,639
7,164
9,436
13,490
15,444
18,547
19,877
22,826
25,613
25,869
24,935
31,374
27,019
31,518
32,522
34,782
44,675
51,649
58,952
58,95251,64944,67534,78232,52231,51827,01931,37424,93525,86925,61322,82619,87718,54715,44413,4909,4367,1644,6393,9752,9842,3481,1921,1927005116416417772,3971,1521,15262252243726738241334330232626621932621724320118720900
       Short-term Debt 
0
0
0
0
0
0
10
40
28
23
67
27
92
98
106
100
100
100
214
100
206
25
77
125
167
63
684
247
247
270
723
815
600
1,071
1,754
779
674
438
63
671
598
704
702
3,553
2,644
1,494
1,152
1,534
4,522
7,021
5,681
5,6817,0214,5221,5341,1521,4942,6443,553702704598671634386747791,7541,0716008157232702472476846316712577252061002141001001001069892276723284010000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
815
600
1,071
1,754
779
674
438
63
63
63
0
0
2,797
1,822
736
426
328
4,074
6,346
0
06,3464,0743284267361,8222,797006363634386747791,7541,0716008150000000000000000000000000000000
       Accounts payable 
0
0
118
187
91
112
207
285
191
243
259
274
99
314
134
111
280
422
352
0
753
562
700
0
473
446
684
0
850
1,996
2,017
2,998
3,687
5,628
7,052
10,408
13,430
11,664
9,257
9,059
11,676
11,939
10,798
10,107
6,903
9,593
9,637
11,085
12,395
15,052
15,867
15,86715,05212,39511,0859,6379,5936,90310,10710,79811,93911,6769,0599,25711,66413,43010,4087,0525,6283,6872,9982,0171,996850068444647307005627530352422280111134314992742592431912852071129118711800
       Other Current Liabilities 
0
0
91
0
110
131
10
40
191
243
259
274
152
314
141
57
57
422
57
0
192
1,810
700
0
473
0
684
0
19
30
10
53
50
162
217
1,386
13,430
5,062
9,121
11,596
11,550
11,233
11,082
12,167
11,576
14,762
15,493
10,833
12,088
12,147
18,746
18,74612,14712,08810,83315,49314,76211,57612,16711,08211,23311,55011,5969,1215,06213,4301,38621716250531030190684047307001,8101920574225757141314152274259243191401013111009100
   > Long-term Liabilities 
0
0
0
48
43
39
35
30
26
22
18
13
9
5
0
0
128
66
157
0
0
0
0
0
0
0
0
0
604
1,280
130
600
1,361
740
3,958
385
363
9,593
11,137
1,279
8,323
5,286
5,343
1,597
14,212
14,134
19,253
18,133
15,481
14,231
19,563
19,56314,23115,48118,13319,25314,13414,2121,5975,3435,2868,3231,27911,1379,5933633853,9587401,3616001301,280604000000000157661280059131822263035394348000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,252
10,820
0
0
0
0
0
13,423
13,539
0
0
0
0
0
0000013,53913,4230000010,8209,2520000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,656
3,778
3,881
3,996
4,111
0
4,336
4,451
4,566
4,678
5,033
0
0
0
0
0
000005,0334,6784,5664,4514,33604,1113,9963,8813,7783,65600000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
570
1,332
711
3,930
100
100
100
100
100
7,117
4,415
4,638
1,023
0
319
0
0
0
0
0
0000031901,0234,6384,4157,1171001001001001003,9307111,3325700000000000000000000000000000000
> Total Stockholder Equity
0
0
-7,436
135
121
180
41
195
83
15
-30
-139
-136
-166
-137
100
77
278
300
0
-355
-1,060
818
0
882
1,316
1,254
0
898
-1,515
-470
-988
-3,394
-4,410
-7,294
1,354
3,704
-3,150
-13,562
26,851
17,398
7,847
3,883
-6,830
-7,330
-10,989
-12,671
3,505
-845
-4,206
-7,720
-7,720-4,206-8453,505-12,671-10,989-7,330-6,8303,8837,84717,39826,851-13,562-3,1503,7041,354-7,294-4,410-3,394-988-470-1,51589801,2541,3168820818-1,060-355030027877100-137-166-136-139-30158319541180121135-7,43600
   Common Stock
0
0
289
289
289
294
294
301
302
302
307
307
307
306
307
320
320
343
347
0
356
405
443
0
445
439
453
0
458
469
534
534
541
711
156
234
259
266
269
307
309
310
315
316
320
326
348
384
407
418
419
41941840738434832632031631531030930726926625923415671154153453446945804534394450443405356034734332032030730630730730730230230129429428928928900
   Retained Earnings Total Equity00000-202,858-195,348-190,563-177,851-169,7930-141,921-122,938-108,585-91,754-80,15200000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000-3840-5,0330000000000-3,54100000000000000000-679-679000-63600000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77,779
91,586
101,451
105,275
164,518
0
173,157
177,132
179,015
183,184
186,674
0
0
0
0
0
00000186,674183,184179,015177,132173,1570164,518105,275101,45191,58677,77900000000000000000000000000000000000
   Treasury Stock00000-164-164-164-164-1640-164-164-164-164-16400000000000000000000000000000000000
   Other Stockholders Equity 
0
0
7,436
7,641
7,668
7,739
7,739
7,958
7,985
7,989
8,043
8,713
8,080
8,072
8,092
9,046
8,405
8,783
9,028
0
8,983
9,273
11,055
0
11,337
11,756
12,229
0
12,581
12,959
14,879
15,073
16,304
18,584
40,451
77,616
91,422
101,287
105,112
164,354
168,863
172,994
176,968
178,852
183,020
191,543
196,738
217,387
220,557
224,838
227,231
227,231224,838220,557217,387196,738191,543183,020178,852176,968172,994168,863164,354105,112101,28791,42277,61640,45118,58416,30415,07314,87912,95912,581012,22911,75611,337011,0559,2738,98309,0288,7838,4059,0468,0928,0728,0808,7138,0437,9897,9857,9587,7397,7397,6687,6417,43600



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.